Novo Nordisk agreed to pay up to $2 billion for the rights to a developmental weight-loss and obesity drug from Chinese pharmaceutical company The United Bio-Technology Co., as it looks to boost its ...

The S&P 500, Dow industrials and Nasdaq climbed as the U.S. looked set to limit the range of import levies it introduces next week. Tariffs on industrial sectors like cars and microchips are no longer ...